Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Cash from Operations (2020 - 2025)

Rapid Micro Biosystems' Cash from Operations history spans 6 years, with the latest figure at 9051000.0 for Q3 2025.

  • For Q3 2025, Cash from Operations fell 5.24% year-over-year to 9051000.0; the TTM value through Sep 2025 reached 37725000.0, up 13.75%, while the annual FY2024 figure was 44153000.0, 2.06% up from the prior year.
  • Cash from Operations for Q3 2025 was 9051000.0 at Rapid Micro Biosystems, up from 9700000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 8600000.0 in Q3 2024 and bottomed at 19309000.0 in Q3 2021.
  • The 5-year median for Cash from Operations is 11262000.0 (2021), against an average of 12134789.47.
  • The largest annual shift saw Cash from Operations tumbled 149.22% in 2021 before it soared 41.61% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 12887000.0 in 2021, then grew by 9.56% to 11655000.0 in 2022, then grew by 18.52% to 9497000.0 in 2023, then fell by 4.34% to 9909000.0 in 2024, then rose by 8.66% to 9051000.0 in 2025.
  • Per Business Quant, the three most recent readings for RPID's Cash from Operations are 9051000.0 (Q3 2025), 9700000.0 (Q2 2025), and 9065000.0 (Q1 2025).